NEW YORK (AP) — The U.S. biotech industry became profitable for the first time in 2008, a new report says, but the global financial crisis has led to a funding drought that could make the road ahead more difficult.
ELIANE ENGELER Associated Press Writer GENEVA (AP) — The World Health Organization said it was starting to ship 2.4 million treatments of antiflu drugs to the 72 countries "most in need" on Tuesday.
Hyperion Therapeutics Receives Orphan Drug Designation for HPN-100 for theTreatment of Urea Cycle DisordersMay 5, 2009 4:42 am | News | Comments
Hyperion Therapeutics,Inc. has announced that HPN-100 has received orphan product designation fromthe FDA for maintenance treatment of patientswith enzymes of the urea cycle.
NEW YORK (AP) — Biotechnology company Amylin Pharmaceuticals has applied for Food and Drug Administration approval of its once-weekly diabetes treatment.
Pfizer Inc has announced that Freda Lewis-Hall, M.D., has been appointed as Chief Medical Officer and Senior Vice President, Pfizer Inc. Dr.
InCube Labs, one of America’s most successful medical innovation centers, has broadened its focus to include pharmaceuticals and cell biology, and created an interdisciplinary team focused on tissue engineering and innovative drug delivery platforms.
Medifacts International, Inc., a global provider of noninvasive cardiac diagnostic services, has announced the award of a $3.1 million contract with a top 5 global pharmaceutical company to provide comprehensive cardiac safety and efficacy services for a large late stage clinical trial.
PHOENIX (AP) — Social-networking sites such as Facebook and Twitter are being considered for inclusion in a system that would warn people with asthma when particulate pollution in their neighborhoods reaches levels that could trigger an attack.
Ranbaxy Pharmaceuticals Inc. (RPI) is conducting a voluntary recall of all lots ofNitrofurantoin (Monohydrate/Macrocrystals) Capsules, USP 100 mg currently onthe market in the U.S.
ACADIA Pharmaceuticals and Biovail Form Collaboration to Develop and Commercialize Pimavanserin in North AmericaMay 4, 2009 4:44 am | News | Comments
ACADIA Pharmaceuticals Inc. has established a collaboration with Biovail Laboratories International SRL, a subsidiary of Biovail Corporation, to co-develop and commercialize pimavanserin, ACADIA's proprietary and selective 5-HT2A inverse agonist, in the United States and Canada.
AstraZeneca has announced the submission of a new drug application (NDA) to the U.S.Food and Drug
RESEARCH TRIANGLE PARK, N.C. (AP) — GlaxoSmithKline, the world's second-largest drugmaker, said Friday it has boosted production of antiviral medication as the U.S. government reported two dozen additional cases of swine flu.
The U.S. Food and Drug Administration and the Federal Trade Commission are alerting the public to be wary of Internet sites and other promotions for products that claim to diagnose, prevent, mitigate, treat or cure the 2009 H1N1 influenza virus.
The FDA is warning consumers to immediately stop using Hydroxycut products by Iovate Health Sciences Inc., of Oakville, Ontario and distributed by Iovate Health Sciences USA Inc. of Blasdell, N.Y. Some Hydroxycut products are associated with a number of serious liver injuries.
ALEX DOMINGUEZ Associated Press Writer BALTIMORE (AP) — With a swine flu outbreak spreading across the nation, more than half the states have yet to stockpile the number of flu-treatment doses recommended by the federal government, an Associated Press survey found.